These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9723387)

  • 1. Cholesterol levels long-term after liver transplant.
    Atillasoy E; Gurkan A; Mor E; Altaca G; Sheiner P; Guy S; Schwartz M; Miller C; Berk P; Emre S
    Transplant Proc; 1998 Aug; 30(5):2049-50. PubMed ID: 9723387
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy.
    Charco R; Cantarell C; Vargas V; Capdevila L; Lázaro JL; Hidalgo E; Murio E; Margarit C
    Liver Transpl Surg; 1999 May; 5(3):204-8. PubMed ID: 10226111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of cyclosporine- vs tacrolimus-based immunosuppression in pediatric liver transplantation.
    Andrews WS; Sommerauer J; Conlin C; Moore P
    Transplant Proc; 1996 Apr; 28(2):897-8. PubMed ID: 8623452
    [No Abstract]   [Full Text] [Related]  

  • 4. Tacrolimus is associated with a lower incidence of cardiovascular complications in liver transplant recipients.
    Rabkin JM; Rosen HR; Corless CL; Olyaei AJ
    Transplant Proc; 2002 Aug; 34(5):1557-8. PubMed ID: 12176483
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiovascular and metabolic complications after liver transplantation: Neoral- versus tacrolimus-based immunosuppression.
    Risaliti A; Baccarani U; Vianello V; Donini A; Adani GL; Sainz M; Montanaro D; Alessandrini V; Bresadola F
    Transplant Proc; 2001; 33(7-8):3684-5. PubMed ID: 11750569
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of long-term cyclosporine or FK 506 therapy on glucose and lipid metabolism in stable liver graft recipients.
    Loss M; Winkler M; Schneider A; Brinkmann C; Manns M; Ringe B; Pichlmayr R
    Transplant Proc; 1995 Feb; 27(1):1136-9. PubMed ID: 7533365
    [No Abstract]   [Full Text] [Related]  

  • 7. Changes in renal function in long-term survivors of liver transplantation: a comparison between cyclosporine microemulsion and tacrolimus therapy.
    Charco R; Cantarell C; Castells LI; Bilbao I; Hidalgo E; Capdevila L; Margarit C
    Transplant Proc; 2002 Aug; 34(5):1548-9. PubMed ID: 12176478
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation: long-term results.
    Pratschke J; Neuhaus R; Tullius SG; Jonas S; Bechstein WO; Neuhaus P
    Transplant Proc; 1998 Jun; 30(4):1419-21. PubMed ID: 9636575
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined liver-kidney transplantation: our experience.
    Torregrosa JV; Iñigo P; Navasa M; Rimola A; Grande L; Oppenheimer F
    Transplant Proc; 1999 Sep; 31(6):2308. PubMed ID: 10500591
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus).
    Van Buren D; Payne J; Geevarghese S; MacDonell R; Chapman W; Wright JK; Helderman JH; Richie R; Pinson CW
    Transplant Proc; 1998 Jun; 30(4):1401-2. PubMed ID: 9636566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immunosuppression.
    Ghobrial RM; Colquhoun S; Rosen H; Hollis P; Ponthieux S; Pakrasi A; Farmer DG; Markman JF; Markowitz J; Drazan K; Yersiz H; Singer J; Stribling R; Arnout W; Holt CD; Goss J; Imagawa D; Seu P; Goldstein LI; Shackleton CR; Martin P; Busuttil RW
    Transplant Proc; 1998 Jun; 30(4):1470-1. PubMed ID: 9636597
    [No Abstract]   [Full Text] [Related]  

  • 12. Does conversion of immunosuppressive monotherapy from cyclosporine A to tacrolimus improve bone mineral density in long-term stable liver transplant recipients?
    Ott R; Bussenius-Kammerer M; Koch CA; Yedibela S; Kissler H; Hohenberger W; Müller V
    Transplant Proc; 2003 Dec; 35(8):3032-4. PubMed ID: 14697971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid profiles after liver transplantation in patients receiving tacrolimus or cyclosporin.
    Aguirrezabalaga J; Fernandez-Selles C; Fraguela J; Otero A; Suarez F; Gómez M
    Transplant Proc; 2002 Aug; 34(5):1551-2. PubMed ID: 12176480
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation.
    Jain A; Mazariegos G; Kashyap R; Green M; Gronsky C; Starzl TE; Fung J; Reyes J
    Transplantation; 2000 Aug; 70(4):617-25. PubMed ID: 10972220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the use of marginal liver grafts justified?
    Mueller AR; Platz KP; Krause P; Steinmüller T; Glanemann M; Neumann U; Lobeck H; Neuhaus P
    Transplant Proc; 1999; 31(1-2):401-2. PubMed ID: 10083160
    [No Abstract]   [Full Text] [Related]  

  • 16. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight.
    Neal DA; Gimson AE; Gibbs P; Alexander GJ
    Liver Transpl; 2001 Jun; 7(6):533-9. PubMed ID: 11443583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weight gain and lipid profile changes in liver transplant recipients: long-term results of the American FK506 Multicenter Study.
    Mor E; Facklam D; Hasse J; Sheiner P; Emre S; Schwartz M; Miller C
    Transplant Proc; 1995 Feb; 27(1):1126. PubMed ID: 7533363
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation.
    Bilbao I; Pou L; Allende E; Lázaro JL; Charco R; Hidalgo E; Margarit C
    Transplant Proc; 2001 May; 33(3):2124-6. PubMed ID: 11377472
    [No Abstract]   [Full Text] [Related]  

  • 19. Homocysteine levels among transplant recipients: effect of immunosuppressive protocols.
    Mor E; Helfmann L; Lustig S; Bar-Nathan N; Yussim A; Sela BA
    Transplant Proc; 2001 Sep; 33(6):2945-6. PubMed ID: 11543802
    [No Abstract]   [Full Text] [Related]  

  • 20. Reasons for long-term use of steroid in primary adult liver transplantation under tacrolimus.
    Jain A; Kashyap R; Marsh W; Rohal S; Khanna A; Fung JJ
    Transplantation; 2001 Apr; 71(8):1102-6. PubMed ID: 11374410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.